AshleyLoveSumrallMDFACP

Cancer Genetics/Cancer Risk Assessment, Head & Neck Cancer, Neuro-Oncology

Levine Cancer Institute

Dr. Sumrall is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1021 Morehead Medical Dr
Ste A
Charlotte, NC 28204
Phone+1 980-442-2000

Duke University HospitalFellowship, Neuro-Oncology, 2010 - 2011
University of Mississippi Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
University of Mississippi Medical CenterResidency, Internal Medicine, 2005 - 2007
University of Mississippi Medical CenterInternship, Internal Medicine, 2004 - 2005
University of Mississippi School of MedicineClass of 2004

PubMed

Using Federal, State, and Grassroots Advocacy to Effect Change in Cancer Care Delivery and Patient Outcomes in the United States.
Brian Persing, Jasmine Kamboj, Ashley Sumrall, Gina Hoxie
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2024-06-01
7 citations
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.
Isabel Arrillaga-Romany, Sharon L Gardner, Yazmin Odia, Dolly Aguilera, Joshua E Allen
Journal of Clinical Oncology. 2024-05-01
35 citations
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, Sebastian M Waszak, Stefan R Sweha
Cancer Discovery. 2023-11-01

Q&A: Specialist Says Neuro-Oncology Needs More Awareness, Funding, ResearchAugust 24th, 2021
WSJ News Exclusive | Costly Brain-Cancer Drug No Longer Covered by MedicareJune 18th, 2021
Costly Brain-Cancer Drug No Longer Covered by MedicareJune 17th, 2021
Join now to see all